Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1602, 2007-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Montelukast reduces resource use in asthma/SAR
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 535, 2007-01 ,pp. :
Access to resources
Recommend
Montelukast reduces eosinophilic inflammation in patients with asthma
Inpharma, Vol. 1, Iss. 1335, 2002-01 ,pp. :
Montelukast reduces inflammation, improves QOL in asthma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 492, 2005-01 ,pp. :
Montelukast cuts use, cost of asthma/allergy medications
Inpharma, Vol. 1, Iss. 1511, 2005-01 ,pp. :
Parecoxib reduces postop resource use
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 540, 2007-01 ,pp. :